Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding CervoMed Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CRVO: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders4548+3
Shares2.13M2.20M+71.5K (+3.4%)
Value$17.3M$17.4M+$160.3K (+0.9%)

New holders (9)

Institutions that held CervoMed Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CRVO in Q4 2025
InstitutionSharesValue% of portfolio
Byrne Asset Management LLC14,700$116.1K0.06%
HRT Financial LP14,330$113.0K0.00%
Dimensional Fund Advisors LP13,951$110.2K0.00%
Jane Street Group, LLC11,076$87.5K0.00%
XTX Topco Ltd10,307$81.4K0.00%
Bank of New York Mellon Corp10,003$79.0K0.00%
Newbridge Financial Services Group, Inc.3,000$23.7K0.00%
Caitong International Asset Management Co., Ltd7$550.00%
Dauntless Investment Group, LLC1$80.00%

Sold out (6)

Institutions that held CervoMed Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CRVO in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Hilton Capital Management, LLC17,315$140.1K
Readystate Asset Management LP14,534$117.6K
Principal Securities, Inc.1,665$13.5K
Royal Bank of Canada1,572$13.0K
Aventura Private Wealth, LLC68$550
Northwestern Mutual Wealth Management Co1$8